Raleigh Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-358
Closed -$9.94K – 972
2023
Q4
$9.94K Buy
358
+16
+5% +$416 ﹤0.01% 587
2023
Q3
$9.59K Buy
342
+33
+11% +$967 ﹤0.01% 540
2023
Q2
$9.68K Buy
309
+117
+61% +$3.54K ﹤0.01% 492
2023
Q1
$5.41K Buy
192
+37
+24% +$1.01K ﹤0.01% 603
2022
Q4
$4.05K Buy
155
+68
+78% +$1.63K ﹤0.01% 574
2022
Q3
$2K Buy
+87
New +$2.26K ﹤0.01% 629

Other funds holding ALKS

Raleigh Capital Management's ALKS Position: Q1 2024 in Review

Raleigh Capital Management sold out of Alkermes (ALKS) in Q1 2024, closing a stake of 358 shares — an estimated $9.94K sold.

Raleigh Capital Management first reported a position in ALKS in Q3 2022 and held it in 6 quarters. The position peaked at $9.94K in Q4 2023. 335 funds tracked by Wall St. Rank hold ALKS as of Q1 2024.

  • Raleigh Capital Management reported no remaining Alkermes position as of Q1 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 358 Alkermes shares in Q1 2024, an estimated $9.94K.
  • Raleigh Capital Management first reported a position in Alkermes in Q3 2022 and held it in 6 quarters.
  • Raleigh Capital Management's Alkermes position peaked at $9.94K in Q4 2023.
  • 335 funds tracked by Wall St. Rank held Alkermes as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.